Candel Therapeutics (NASDAQ:CADL) Stock Rating Upgraded by Wall Street Zen
Candel Therapeutics (NASDAQ:CADL – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Thursday. Several other brokerages have also recently issued reports on CADL. Canaccord Genuity Group upped their target price on shares of Candel Therapeutics from $20.00 to […]
Candel Therapeutics (NASDAQ:CADL – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Thursday. Several other brokerages have also recently issued reports on CADL. Canaccord Genuity Group upped their target price on shares of Candel Therapeutics from $20.00 to […]
